Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update

Johnson, JA; Caudle, KE; Gong, L; Whirl‐Carrillo, M; Stein, CM; Scott, SA; Lee, MT; Gage, BF; Kimmel, SE; Perera, MA; Anderson, JL; Pirmohamed, M; Klein, TE; Limdi, NA; Cavallari, LH; Wadelius, M

doi:10.1002/cpt.668

Public

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update

Shared by NobleBlocks on Apr 4, 2017 • 12:00 AM UTC

Authors:

JA Johnson

KE Caudle

L Gong

Abstract

This document is an update to the 2011 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C9 and VKORC1 genotypes and warfarin dosing. Evidence from the published literature is presented for CYP2C9 , VKORC1 , CYP4F2 , and rs12777823 genotype‐guided warfarin dosing to achiev...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!